Measurement of Gemcitabine Metabolites in Blood and Urine as Predictors of Response to GemX Bladder Radiotherapy (Gemtrans)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by Christie Hospital NHS Foundation Trust
Sponsor:
Collaborator:
University of Oxford
Information provided by (Responsible Party):
Rebecca Robinson, Christie Hospital NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT01343121
First received: April 7, 2011
Last updated: July 22, 2014
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)